Details of SAPdb entry with Sequence KFA |
Primary information | |
---|---|
SAPdb ID | 1067, |
PMID | 23598886 |
Peptide Name | (L-Lys)-(L-Phe)-(L-Ala) |
Peptide sequence | KFA |
N-Terminal Modification | Free |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Conjugate |
Conjugate partner | perylene diimide (PDI) |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy), FTIR (Fourier Transform Infrared) Spectroscopy (Fourier Transform Infrared) Spectroscopy and CD (Circular Dichroism spectroscopy) |
Solvent | THF(< 10uM) |
Method | Peptide is soluble in tetrahydrofuran (THF) it becomes partially soluble. Upon heating a peptide solution at concentration 10x10-4 M to 60 °C for several minutes and then this solution was sonicated (0.40 W cm2 and 40 KHz) for 30–60 min and then kept to 3–5 °C in the refrigerator for 2 days, self-assembled structure formed. |
Conc | > 1.0x 10-5 M |
Temperature | 3-5°C |
Incubation Time | 2 days |
Year | 2013 |
Self assembly | Yes |
Type of Self assembly | Left handed Nanohelicals structure |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
NA | |
Nanohelicals | |
NA | |
None | |
N[C@@H](CCCC[NH3])C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C=O | |
Primary information | |
SAPdb ID | 1068, |
PMID | 23598886 |
Peptide Name | (L-Lys)-(L-Phe)-(L-Ala) |
Peptide sequence | KFA |
N-Terminal Modification | Free |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Conjugate |
Conjugate partner | perylene diimide (PDI) |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy), FTIR (Fourier Transform Infrared) Spectroscopy (Fourier Transform Infrared) Spectroscopy and CD (Circular Dichroism spectroscopy) |
Solvent | THF(< 10uM) |
Method | Peptide is soluble in tetrahydrofuran (THF) it becomes partially soluble. Upon heating a peptide solution at concentration 10x10-4 M to 60 °C for several minutes and then cooling to 3–5 °C in the refrigerator for 2 days, self-assembled structure formed. |
Conc | > 1.0x 10-5 M |
Temperature | 3-5°C |
Incubation Time | 2 days |
Year | 2013 |
Self assembly | Yes |
Type of Self assembly | Right handed Nanohelicals structure |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
NA | |
Nanohelicals | |
NA | |
None | |
N[C@@H](CCCC[NH3])C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C=O | |
Primary information | |
SAPdb ID | 1069, |
PMID | 23598886 |
Peptide Name | (L-Lys)-(L-Phe)-(L-Ala) |
Peptide sequence | KFA |
N-Terminal Modification | Free |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Conjugate |
Conjugate partner | perylene diimide (PDI) |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy), FTIR (Fourier Transform Infrared) Spectroscopy (Fourier Transform Infrared) Spectroscopy and CD (Circular Dichroism spectroscopy) |
Solvent | THF(< 10uM) |
Method | Peptide is soluble in tetrahydrofuran (THF) it becomes partially soluble. Upon heating a peptide solution at concentration 10x10-4 M to 60 °C for several minutes and then cooling to 3–5 °C in the refrigerator for 2 days, self-assembled structure formed. |
Conc | > 2.0x 10-5 M |
Temperature | 3-5°C |
Incubation Time | 2 days |
Year | 2013 |
Self assembly | Yes |
Type of Self assembly | Nanoparticle |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
NA | |
Nanoparticle | |
5 | |
None | |
N[C@@H](CCCC[NH3])C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C=O | |
Primary information | |
SAPdb ID | 1120, |
PMID | 21472901 |
Peptide Name | 1 or Boc-{(N-Cbz)-Lys}-Phe-Ala |
Peptide sequence | KFA |
N-Terminal Modification | N-Cbz lysine (Cbz = benzyloxy-carbonyl) and Boc (N-t-Butoxycarbonyl) |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Peptide derivative |
Conjugate partner | Coupling with 5,5’-dibromomethyl-2,2’-bipyridin |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy) NMR and Mass spectrometery |
Solvent | THF (Tetrahydrofuran):Water (1:1) |
Method | Conjugate 1 was dissolved in THF at a concentration of 4.0mg/mL. Addition of the same amount of water into the prior solution in THF resulted in a transparent solution and the formation of vesicles. |
Conc | 2mg/ml |
Temperature | Room temperature |
Year | 2011 |
Self assembly | Yes |
Type of Self assembly | vesicle structure |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
Stable | |
Nanovesicle | |
5 | |
None | |
N.A. | |
Primary information | |
SAPdb ID | 1121, |
PMID | 21472901 |
Peptide Name | 1 or Boc-{(N-Cbz)-Lys}-Phe-Ala |
Peptide sequence | KFA |
N-Terminal Modification | N-Cbz lysine (Cbz = benzyloxy-carbonyl) and Boc (N-t-Butoxycarbonyl) |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Peptide derivative |
Conjugate partner | Coupling with 5,5’-dibromomethyl-2,2’-bipyridin |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy) NMR and Mass spectrometery |
Solvent | THF (Tetrahydrofuran):Water (1:1) |
Method | Conjugate 1 was dissolved in THF at a concentration of 4.0mg/mL. Addition of the same amount of water into the prior solution in THF resulted in a transparent solution and the formation of vesicles. Upon ultrasound treatment for about 10 mins, the vesicles transferred into networks of nanofibers |
Conc | 2mg/ml |
Temperature | Room temperature |
Incubation Time | 20-30minutes |
Year | 2011 |
Self assembly | Yes |
Type of Self assembly | Nanofibril structure |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
Stable | |
Nanofibers | |
150 | |
None | |
N.A. | |
Primary information | |
SAPdb ID | 1122, |
PMID | 21472901 |
Peptide Name | 1 or Boc-{(N-Cbz)-Lys}-Phe-Ala |
Peptide sequence | KFA |
N-Terminal Modification | N-Cbz lysine (Cbz = benzyloxy-carbonyl) and Boc (N-t-Butoxycarbonyl) |
C-Terminal Modification | Free |
Non-Terminal Modification | None |
Length | 3 |
Peptide/Conjuagate | Peptide derivative |
Conjugate partner | Coupling with 5,5’-dibromomethyl-2,2’-bipyridin |
Technique | TEM (Transmission Electron Microscopy), SEM (Scanning Electron Microscopy) NMR and Mass spectrometery |
Solvent | THF (Tetrahydrofuran):Water (1:1) |
Method | Conjugate 1 was dissolved in THF at a concentration of 4.0mg/mL. Addition of the same amount of water into the prior solution in THF resulted in a transparent solution and the formation of vesicles. Upon ultrasound treatment for about 10 mins, the vesicles transferred into networks of nanofibers. The nanofibers rearranged into vesicles upon incubation in the 60 C water bath. |
Conc | 2mg/ml |
Temperature | 60°C |
Incubation Time | 20-30minutes |
Year | 2011 |
Self assembly | Yes |
Type of Self assembly | vesicle structure |
Tertiary Structure (Technique) | Not Predicted), |
Linear | |
NA | |
Stable | |
Nanovesicle | |
NA | |
None | |
N.A. | |